A study of 128 jaundiced term neonates showed that 28 (22 per cent) had hearing loss based on brain stem-evoked response. There was no significant difference in the percentage of neonates with hearing loss between those with peak serum bilirubin levels of less than 340 umol/l (16 per cent) and those with hyperbilirubinaemia >339 fimol/l (33 per cent) (P=Q.\\). Logistic regression analysis showed that severe jaundice which required exchange transfusion and earlier age of onset of hyperbilirubinaemia were statistically significant risk factors associated with hearing loss (P = 0.038 and P=0.012, respectively).
Introduction
There is little evidence so far to support the view that hyperbilirubinaemia above levels of 20 mg/dl (340 /imol/1) are hazardous to the hearing of healthy term neonates.
1 " 16 Neither is any significant risk factor identified as associated with hearing loss in term neonates with jaundice.
The objectives of this study were to determine' (a) the frequency of hearing loss in the jaundiced term neonates; (b) whether hearing loss occurred more frequently in the neonates with peak hyperbilirubinaemia above 339 /(mol/1; and (c) the risk factors associated with hearing loss in this group of neonates.
Materials
Between 1st of June to 31st of December 1984, jaundiced term neonates admitted to our out-born nursery unit were studied prospectively. All babies were given phototherapy. Exchange transfusion was carried out when the indirect serum bilirubin level exceeded: 175 //mol/1 during the first 24 h of life, 250 /imol/1 between 24 and 48 h of life and 340/miol/l after more than 48 h of life. Phototherapy was stopped only when serum bilirubin levels dropped below 180 //mol/1 after 48 h of age.
The neonates were screened for hearing loss by brain stem auditory-evoked response (BSER) on the day of discharge by one of us (MO) who had no knowledge of the patients' treatment or serum bilirubin levels. The stimulus was produced by the stimulus generator of a Racia APE 78 evoked potential recorder. Responses were considered to be normal if a wave V could be consistently produced for a stimulus of 25 dB nHL. If there was no response, the intensity of the stimulus was increased by 5 dB steps until a consistent response was obtained. Mild hearing loss was diagnosed when there was no response to clicks at 45 dB nHL, moderate hearing loss at 65 dB nHL and severe hearing loss at 85 dBnHL.
Results
During the study period, 136 jaundiced term neonates were admitted to the nursery. Eight of them were excluded from the study because of: aminoglycoside treatment (n = 5), congenital cyanotic heart disease (n= 1), and congenital infection (n = 2).
The results of the remaining 128 neonates are presented here. There were 80 males and 48 females. Their mean age of onset of jaundice was 3.4 days (SD = 2.1). Their mean peak indirect serum bilirubin level was 311.9 /jmol/1 (SD= 124.2). The mean age when BSER was recorded was 11.6 days (SD = 3.9). Hearing loss was detected in 28 (21.9 per cent) neonates. Two of them manifested signs of kernicterus.
Eighty-three (65 per cent) of the 128 neonates had peak total serum bilirubin levels below 340 //mol/1. Hearing loss was present in 13 of these 83 babies (16 per cent; 95 per cent confidence intervals: 7.8-23.5 per cent). Of the 13 neonates with hearing loss, only one had exchange transfusion. Three (23 per cent) of them had bilateral severe hearing loss while the remaining 10 (76.9 per cent) had mild unilateral (n = 2) or bilateral (n = 8) hearing loss.
Forty-five (35 per cent) of the 128 neonates had peak total serum bilirubin levels above 339 /<mol/l. Hearing loss was present in 15 of them (33 per cent; 95 per cent confidence intervals: 20-47 per cent). All of these 15 affected neonates underwent exchange transfusion. Six (40 per cent) of them had severe unilateral (n = 2) or N Y BOO ET AL bilateral (n=4) hearing loss. The remaining nine neonates (60 per cent) had mild unilateral (n = 5) or bilateral (n = 4) hearing loss. When compared with neonates with lower peak total hyperbilirubinaemia, a higher percentage of the neonates with severe hyperbilirubinaemia (> 339 /(mol/1) had hearing loss. However, the difference in the percentage (18 per cent) of neonates with hearing loss between these two groups was statistically not significant (95 per cent confidence intervals 1.8-33.4 per cent, P = 0.\l).
Logistic regression analysis controlling for the various confounding factors (Table 1) showed that the significant risk factors associated with hearing loss in the term jaundiced neonates were (Table 2) severe hyperbilirubinaemia which needed exchange transfusion (Exchge) and the age of onset of hyperbilirubinaemia (AgeOnset). The probability of hearing loss was estimated by 1/(1 +e~x), where ,x= 19.73 -3.092(Exchge) -0.5183(AgeOnset), the presence and absence of exchange transfusion is expressed as 0 and 1, and the age of onset of hyperbilirubinaemia is expressed in days, respectively.
Discussion
Contrary to the studies by Culley el al? and Holmes et al. 11 ours showed that hearing loss was not uncommon in the jaundiced term neonates. Our results confirm the findings by other workers which showed similar absence of correlation between peak serum bilirubin and the extent of abnormal BSER.
1018 " 22 Our study showed that an early age of onset of jaundice and hyperbilirubinaemia severe enough to require exchange transfusion were significant risk factors associated with hearing loss in term neonates. The increased risk of hearing loss with earlier onset of jaundice could be due to the greater vulnerability of the auditory nerves to bilirubin toxin at a younger age. As the neonate matured, this vulnerability decreased.
Wennberg et al. 9 and Nakamura et al. 11 observed that an improvement in the BSER occurred in the jaundiced neonates following exchange transfusion. Based on their findings, it was possible that many more of the neonates in our series would have hearing loss had exchange transfusion not been carried out. Thus, until more reliable indicators of bilirubin toxicity have been identified, we recommend that the current practice of carrying out exchange transfusion in the term neonates with severe hyperbilirubinaemia should be continued to reduce the incidence of hearing loss.
